{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:18:43Z","timestamp":1790165923275,"version":"4.1.0"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/mco.0b013e3280d646b8","type":"journal-article","created":{"date-parts":[[2007,4,5]],"date-time":"2007-04-05T04:04:40Z","timestamp":1175745880000},"page":"297-303","source":"Crossref","is-referenced-by-count":39,"title":["Role of branched-chain amino acids in liver disease: the evidence for and against"],"prefix":"10.1097","volume":"10","author":[{"given":"Sudeep","family":"Khanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarath","family":"Gopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210204","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"R2-7-20210204","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0168-8278(05)80308-3","article-title":"Nutritional status in cirrhosis.","volume":"21","year":"1994","journal-title":"J Hepatol"},{"key":"R3-7-20210204","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0899-9007(01)00754-7","article-title":"Prognostic value of energy metabolism in patients with viral liver cirrhosis","volume":"18","author":"Tajika","year":"2002","journal-title":"Nutrition"},{"key":"R4-7-20210204","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0148607187011003305","article-title":"Resting energy expenditure in patients with end-stage liver disease and in normal population","volume":"11","author":"Shanbhogue","year":"1987","journal-title":"J Parenter Enteral Nutr"},{"key":"R5-7-20210204","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/hep.1840110309","article-title":"Energy metabolism in patients with acute and chronic liver disease","volume":"11","author":"Schneeweiss","year":"1990","journal-title":"Hepatology"},{"key":"R6-7-20210204","first-page":"203","article-title":"Impairment of taste and olfaction in patients with cirrhosis: the role of vitamin A","volume":"38","author":"Garrett-Laster","year":"1984","journal-title":"Hum Nutr Clin Nutr"},{"key":"R7-7-20210204","first-page":"2422","article-title":"Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C","volume":"46","author":"Giannini","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"R8-7-20210204","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/0016-5085(79)90154-9","article-title":"Bile acid metabolism in cirrhosis. V. Determination of biliary lipid secretion rates in patients with advanced cirrhosis","volume":"77","author":"Schwartz","year":"1979","journal-title":"Gastroenterology"},{"key":"R9-7-20210204","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1572-0241.2003.07475.x","article-title":"Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension","volume":"98","author":"Gunnarsdottir","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R10-7-20210204","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1172\/JCI106497","article-title":"Action of neomycin on intraluminal phase of lipid absorption","volume":"50","author":"Thompson","year":"1971","journal-title":"J Clin Invest"},{"key":"R11-7-20210204","first-page":"118","article-title":"Malabsorption and nutritional abnormalities in patients with liver cirrhosis","volume":"22","author":"Romiti","year":"1990","journal-title":"Ital J Gastroenterol"},{"key":"R12-7-20210204","first-page":"127","article-title":"Is protein-losing enteropathy a significant complication of portal hypertension","volume":"93","author":"Conn","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R13-7-20210204","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/0148607196020002159","article-title":"Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy","volume":"20","author":"Fabbri","year":"1996","journal-title":"J Parenter Enteral Nutr"},{"key":"R14-7-20210204","article-title":"Branched-chain amino acids for hepatic encephalopathy. The Cochrane Library, issue 2","author":"Als-Nielsen","year":"2004"},{"key":"R15-7-20210204","doi-asserted-by":"crossref","first-page":"1596S","DOI":"10.1093\/jn\/135.6.1596S","article-title":"Branched-chain amino acid supplementation in patients with liver diseases","volume":"135","author":"Marchesini","year":"2005","journal-title":"J Nutr"},{"key":"R16-7-20210204","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(79)92119-6","article-title":"Hyperammonaemia, plasma amino acid imbalance, and blood-brain amino acid transport: a unified theory of portal-systemic encephalopathy","volume":"2","author":"James","year":"1979","journal-title":"Lancet"},{"key":"R17-7-20210204","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0006-291X(02)02339-2","article-title":"Leucine stimulates the secretion of hepatocyte growth factor by hepatic stellate cells","volume":"297","author":"Tomiya","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"R18-7-20210204","first-page":"204","article-title":"Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis","volume":"35","author":"Muto","year":"2006","journal-title":"Hepatol Res"},{"key":"R19-7-20210204","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM199412083312303","article-title":"Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma","volume":"331","author":"Fan","year":"1994","journal-title":"N Engl J Med"},{"key":"R20-7-20210204","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1440-1622.1999.01701.x","article-title":"Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma","volume":"69","author":"Meng","year":"1999","journal-title":"Aust N Z J Surg"},{"key":"R21-7-20210204","first-page":"1525","article-title":"Long-term oral administration of branched-chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial.","volume":"84","year":"1997","journal-title":"Br J Surg"},{"key":"R22-7-20210204","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.nut.2004.07.017","article-title":"Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis","volume":"21","author":"Togo","year":"2005","journal-title":"Nutrition"},{"key":"R23-7-20210204","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1365-2036.2004.01920.x","article-title":"Long-term oral branched-chain amino acids in patients undergoing chemembolization for hepatocellular carcinoma: a randomized trial","volume":"19","author":"Poon","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R24-7-20210204","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1034\/j.1399-0012.2003.00068.x","article-title":"Predictive factors for early mortality following liver transplant","volume":"17","author":"Bilbao","year":"2003","journal-title":"Clin Transplant"},{"key":"R25-7-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-2277.2003.tb00215.x","article-title":"Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation","volume":"16","author":"Tietge","year":"2003","journal-title":"Transpl Int"},{"key":"R26-7-20210204","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1203\/01.pdr.0000219302.21321.87","article-title":"Effect of orthotopic liver transplantation (OLT) on branched-chain amino acid requirement","volume":"59","author":"Mager","year":"2006","journal-title":"Pediatr Res"},{"key":"R27-7-20210204","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/0148607190014004386","article-title":"Nutritional support after liver transplantation: a randomized prospective study","volume":"14","author":"Reilly","year":"1990","journal-title":"J Parenter Enteral Nutr"},{"key":"R28-7-20210204","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(85)80762-5","article-title":"Controlled trial of nutritional supplementation, with and without branched-chain amino acid enrichment, in treatment of acute alcoholic hepatitis","volume":"1","author":"Calvey","year":"1985","journal-title":"J Hepatol"},{"key":"R29-7-20210204","first-page":"1209","article-title":"A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition","volume":"86","author":"Bonkovsky","year":"1991","journal-title":"Am J Gastroenterol"},{"issue":"1 Suppl","key":"R30-7-20210204","doi-asserted-by":"crossref","first-page":"295S","DOI":"10.1093\/jn\/136.1.295S","article-title":"Branched-chain amino acid enriched supplements as therapy for liver disease","volume":"136","author":"Charlton","year":"2006","journal-title":"J Nutr"},{"key":"R31-7-20210204","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jn\/136.4.965","article-title":"Mild to moderate chronic cholestatic liver disease increases leucine oxidation in children","volume":"136","author":"Mager","year":"2006","journal-title":"J Nutr"},{"key":"R32-7-20210204","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jn\/136.1.133","article-title":"Branched-chain amino acid needs in children with mild to moderate chronic cholestatic liver disease","volume":"136","author":"Mager","year":"2006","journal-title":"J Nutr"},{"key":"R33-7-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-006-9006-5","article-title":"Amino acid challenge in patients with cirrhosis and control subjects: ammonia, plasma amino acid and EEG changes","volume":"21","author":"Mardini","year":"2006","journal-title":"Metab Brain Dis"},{"key":"R34-7-20210204","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.meg.0000059162.46867.f0","article-title":"Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis","volume":"15","author":"Iwasa","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R35-7-20210204","doi-asserted-by":"crossref","first-page":"6792","DOI":"10.3748\/wjg.v11.i43.6792","article-title":"Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis","volume":"11","author":"Yamamoto","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R36-7-20210204","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/BF01316578","article-title":"Branched-chain amino acids vs. lactulose in the treatment of hepatic coma. A controlled study","volume":"27","author":"Rossi-Fanelli","year":"1982","journal-title":"Dig Dis Sci"},{"key":"R37-7-20210204","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/hep.1840030402","article-title":"Is intravenous administration of branched-chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study","volume":"3","author":"Wahren","year":"1983","journal-title":"Hepatology"},{"key":"R38-7-20210204","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0676.1985.tb00250.x","article-title":"Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients","volume":"5","author":"Michel","year":"1985","journal-title":"Liver"},{"key":"R39-7-20210204","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/0148607185009003288","article-title":"Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind controlled trial","volume":"9","author":"Cerra","year":"1985","journal-title":"J Parenter Enteral Nutr"},{"key":"R40-7-20210204","first-page":"5","article-title":"Branched-chain enriched amino acid solutions in the treatment of hepatic encephalopathy: a controlled trial","volume":"17","author":"Fiaccadori","year":"1985","journal-title":"Ital J Gastroenterol"},{"key":"R41-7-20210204","first-page":"18","article-title":"Treatment of hepatic encephalopathy: a randomized clinical trial comparing branched-chain enriched amino acid solution to oral neomycin","volume":"6","author":"Strauss","year":"1986","journal-title":"Nutr Supp Services"},{"key":"R42-7-20210204","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0168-8278(90)90135-E","article-title":"Branched-chain enriched amino acids versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis","volume":"10","author":"Vilstrup","year":"1990","journal-title":"J Hepatol"},{"key":"R43-7-20210204","first-page":"482","article-title":"Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial","volume":"104","author":"Kanematsu","year":"1988","journal-title":"Surgery"},{"key":"R44-7-20210204","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0168-8278(05)80210-7","article-title":"Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study","volume":"17","author":"Plauth","year":"1993","journal-title":"J Hepatol"},{"key":"R45-7-20210204","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02023616","article-title":"Branched-chain amino acids in the treatment of latent porto-systemic encephalopathy. A placebo-controlled double-blind cross-over study","volume":"25","author":"Egberts","year":"1986","journal-title":"Z Ernahrungswiss"},{"key":"R46-7-20210204","first-page":"880","article-title":"Usefulness of branched-chain amino acid (BCAA)-enriched nutrient mixture for nutritional treatment undergoing endoscopic treatment for esophageal varices","volume":"102","author":"Shibata","year":"2005","journal-title":"Nippon Shokakibyo Gakkai Zasshi"},{"key":"R47-7-20210204","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1386-6346(03)00152-9","article-title":"Branched-chain amino acids supplements in the late evening decrease the frequency of muscle cramps with advanced hepatic cirrhosis","volume":"26","author":"Sako","year":"2003","journal-title":"Hepatol Res"},{"key":"R48-7-20210204","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/ajcn\/56.1.158","article-title":"Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement","volume":"56","author":"Chin","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"R49-7-20210204","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1542-3565(05)00017-0","article-title":"Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis","volume":"3","author":"Muto","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R50-7-20210204","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/gut.23.10.801","article-title":"Branched-chain amino acids in the treatment of chronic hepatic encephalopathy","volume":"23","author":"Eriksson","year":"1982","journal-title":"Gut"},{"key":"R51-7-20210204","first-page":"644","article-title":"Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver.","volume":"21","author":"Sieg","year":"1983","journal-title":"Z Gastroenterol"},{"key":"R52-7-20210204","first-page":"765","article-title":"Long-term tolerance of a special amino acid oral formula in patients with advanced liver disease","volume":"27","author":"Simko","year":"1983","journal-title":"Nutr Rep Int"},{"key":"R53-7-20210204","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00000658-198303000-00008","article-title":"Comparison of the effects of Hepatic-Aid and a casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients","volume":"197","author":"McGhee","year":"1983","journal-title":"Ann Surg"},{"key":"R54-7-20210204","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/hep.1840040218","article-title":"Comparison of dietary protein with an oral, branched-chain-enriched amino acid supplement in chronic portal-systemic encephalopathy","volume":"4","author":"Horst","year":"1984","journal-title":"Hepatology"},{"key":"R55-7-20210204","first-page":"193","article-title":"Muscle biopsy study on malnutrition in patients with liver cirrhosis","author":"Guarnieri","year":"1984"},{"key":"R56-7-20210204","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/0148607185009006671","article-title":"Enriched branched-chain amino acid formula vs. a casein-based supplement in the treatment of cirrhosis","volume":"9","author":"Christie","year":"1985","journal-title":"J Parenter Enteral Nutr"},{"key":"R57-7-20210204","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0016-5085(85)80004-4","article-title":"Branched-chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled cross-over study","volume":"88","author":"Egberts","year":"1985","journal-title":"Gastroenterology"},{"key":"R58-7-20210204","first-page":"489","article-title":"The effect of dietary supplementation with branched-chain amino acids vs. casein in patients with chronic recurrent portal systemic encephalopathy: a controlled trial","author":"Fiaccadori","year":"1988"},{"key":"R59-7-20210204","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0261-5614(89)90008-3","article-title":"Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake","volume":"8","author":"Swart","year":"1989","journal-title":"Clin Nutr"},{"key":"R60-7-20210204","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0168-8278(90)90278-Y","article-title":"Long term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial","volume":"11","author":"Marchesini","year":"1990","journal-title":"J Hepatol"},{"key":"R61-7-20210204","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0016-5085(03)00323-8","article-title":"Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial","volume":"124","author":"Marchesini","year":"2003","journal-title":"Gastroenterology"},{"issue":"2","key":"R62-7-20210204","first-page":"CD001939","article-title":"Branched-chain amino acids for hepatic encephalopathy.","author":"Als-Nielsen","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R63-7-20210204","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.1840190234","article-title":"Nutritional supplementation in chronic liver disease: an analytical review","volume":"19","author":"Nompleggi","year":"1994","journal-title":"Hepatology"},{"key":"R64-7-20210204","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1098-2825(1999)13:1<31::AID-JCLA6>3.0.CO;2-Y","article-title":"Evaluating response to nutritional therapy using the branched-chain amino acid\/tyrosine ratio in patients with chronic liver disease","volume":"13","author":"Kawamura-Yasui","year":"1999","journal-title":"J Clin Lab Anal"},{"key":"R65-7-20210204","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0148607103027005315","article-title":"Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration","volume":"27","author":"Fukushima","year":"2003","journal-title":"J Parenter Enteral Nutr"}],"container-title":["Current Opinion in Clinical Nutrition &amp; Metabolic Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCO.0b013e3280d646b8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:36:13Z","timestamp":1786034173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00075197-200705000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mco.0b013e3280d646b8","relation":{},"ISSN":["1363-1950"],"issn-type":[{"value":"1363-1950","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}